| 亞洲大學 |
2017-04 |
Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study.
|
Kao, Chao-Yueh Fa；Chao-Yueh Fan；Wen-Yen Huan；Wen-Yen Huang；Chun-Shu Lin；Chun-Shu Lin；Yu-Fu Su；Yu-Fu Su；Cheng-Hsiang；Cheng-Hsiang Lo；Chih-Cheng T；Chih-Cheng Tsao；Ming-Yueh Li；Ming-Yueh Liu；Cheng-Li Lin；Cheng-Li Lin；高嘉鴻；Chia-Hung |
| 臺北醫學大學 |
2013 |
Risk of second primary malignancies following nasopharyngeal carcinoma: a population-based cohort study in Taiwan
|
Lin, C;SW, Lin;SF, Weng;YS, Lin |
| 臺北醫學大學 |
2013 |
Risk of second primary malignancies following nasopharyngeal carcinoma: a population-based cohort study in Taiwan
|
Lin, C;Lin, SW;Weng, SF;Lin, YS |
| 國立臺灣大學 |
2014 |
Risk of second primary malignancies in young patients with colorectal cancer
|
Wu, Hsu; Liang, Yi-Hsin; Shao, Yu Yun; Chen, Ho-Min; Lai, Chiu-Lin; Lin, Zhong-Zhe; Shau, Wen-Yi; Yeh, Kun-Huol; Chong, Ann-Lii; Lal, Mei-Shu; 梁逸歆; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 葉坤輝; 賴秋伶 |
| 國立成功大學 |
2016-12 |
Risk of secondary cancers in women with breast cancer and the influence of radiotherapy A national cohort study in Taiwan
|
Lin, Cheng-Yao; Chen, Sih-Hao; Huang, Chien-Cheng; Weng, Shih-Feng; Lee, Song-Tay; Guo, How-Ran; Kuo, Shu-Chun; Su, Shih-Bin |
| 國立成功大學 |
2024-04 |
Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis
|
Wu;Kuan-Yu;Cheong;Ian-Seng;Lai;Jung-Nien;Hung;Kuo-Chuan;Chen;-Ting, Yi;Chiu;-Ting, Lu;Tsai;Hsin-Tzu;Jou;Yeong-Chin;Tzai;Tzong-Shin;Tsai;Shyan, Yuh- |
| 亞洲大學 |
2019-08 |
Risk of Seizures in Patients with Organophosphate Poisoning: A Nationwide Population-Based Study.
|
Ch, Chieh-Sen; Chuang, Chieh-Sen; Yang, Kai-Wei; Ye, Chia-Ming; Yen, Chia-Ming; Lin, Cheng-Li; 高嘉鴻; Kao, Chia-Hung |
| 臺大學術典藏 |
2020-08-12T06:34:18Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Wang H.-C.;Chen L.;Chong-Jen Yu;Chong-Jen Yu;Wang H.-C.;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Chang Y.-C.;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore) |
| 臺大學術典藏 |
2021-03-19T06:57:17Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.;Lin Y.S.;Wang Y.-H.;Lai C.-C.;Wang H.-C.;Chen L.;Yu C.-J.;Yu C.-J.;Wang H.-C.;Perng D.-W.;Cheng S.-L.;Hsu J.-Y.;Hsu W.-H.;Tsai Y.-H.;Hsiue T.-R.;Lin M.-C.;Lin H.-I.;Wang C.-Y.;Yeun-Chung Chang;Yang U.-C.;Chen C.-M.;Lin C.-S.;Chen L.;Wei Y.-F.;Chong I.-W.;Chen C.-Y.;On The Behalf Of Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore); Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; Yu C.-J.; Yu C.-J.; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2022-06-27T06:59:50Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
